{"id":"da-5219","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By acting as a partial agonist at the 5-HT4 receptor, DA-5219 increases acetylcholine release in the enteric nervous system, thereby promoting coordinated gastric muscle contractions. This mechanism facilitates the movement of food from the stomach into the small intestine, making it useful for treating functional gastrointestinal disorders characterized by impaired gastric motility.","oneSentence":"DA-5219 is a selective serotonin 5-HT4 receptor partial agonist that enhances gastric motility and accelerates gastric emptying.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:08:31.097Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Functional dyspepsia"},{"name":"Gastroparesis"}]},"trialDetails":[{"nctId":"NCT06151210","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis","status":"COMPLETED","sponsor":"Dong-A ST Co., Ltd.","startDate":"2024-01-31","conditions":"Gastritis Acute, Gastritis Chronic","enrollment":467}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"DA-5219","genericName":"DA-5219","companyName":"Dong-A ST Co., Ltd.","companyId":"dong-a-st-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DA-5219 is a selective serotonin 5-HT4 receptor partial agonist that enhances gastric motility and accelerates gastric emptying. Used for Functional dyspepsia, Gastroparesis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}